Hims & Hers Health (HIMS)
(Real Time Quote from BATS)
$15.81 USD
-0.23 (-1.43%)
Updated Aug 8, 2024 03:54 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Hims & Hers Health, Inc. - Hold
Zacks' proprietary data indicates that Hims & Hers Health, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the HIMS shares relative to the market in the next few months. In addition, Hims & Hers Health, Inc. has a VGM Score of A (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that Hims & Hers Health, Inc. may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of HIMS, demonstrate its potential to perform inline with the market. It currently has a Growth Score of A. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
Style Scorecard
Value Scorecard
Growth Scorecard
Momentum Scorecard
Value Score | HIMS: C | Industry [X] | AZTA: C | INSP: D | TXG: D |
---|---|---|---|---|---|
Zacks Rank | 3 | 3 | 3 | 3 | |
VGM Score | A | A | B | F | |
Cash/Price | 0.05 | 0.27 | 0.27 | 0.10 | 0.16 |
EV/EBITDA | -182.71 | -0.86 | 37.52 | -265.06 | -8.72 |
PEG Ratio | NA | 2.99 | NA | NA | NA |
Price/Book (P/B) | 9.52 | 1.33 | 1.44 | 8.77 | 3.01 |
Price/Cash Flow (P/CF) | NA | 6.55 | 32.53 | NA | NA |
P/E (F1) | 70.34 | 25.61 | 181.13 | 1,274.75 | NA |
Price/Sales (P/S) | 3.23 | 1.51 | 3.95 | 7.96 | 3.45 |
Earnings Yield | 1.43% | -8.33% | 0.55% | 0.08% | -8.44% |
Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash Flow ($/share) | -0.09 | -0.45 | 1.63 | -0.70 | -1.26 |
Growth Score | HIMS: A | Industry [X] | AZTA: A | INSP: B | TXG: D |
---|---|---|---|---|---|
Zacks Rank | 3 | 3 | 3 | 3 | |
VGM Score | A | A | B | F | |
Hist. EPS Growth | NA | -21.08% | -25.73% | NA% | NA% |
Proj. EPS Growth | 307.30% | 28.57% | -5.38% | 120.53% | 7.57% |
Curr. Cash Flow Growth | -66.30% | -19.88% | 9.23% | -51.71% | 13.16% |
Hist. Cash Flow Growth | NA | 9.01% | 3.34% | 0.68% | -9.30% |
Current Ratio | 2.68 | 2.15 | 4.78 | 9.25 | 5.22 |
Debt/Capital | 0.00% | 5.97% | 0.00% | 0.00% | 0.00% |
Net Margin | 1.70% | -42.20% | -23.66% | 0.85% | -42.20% |
Return on Equity | 5.25% | -44.95% | 0.89% | 1.03% | -30.85% |
Sales/Assets | 2.39 | 0.49 | 0.25 | 1.03 | 0.65 |
Proj. Sales Growth (F1/F0) | 55.64% | 0.28% | -0.70% | 27.06% | 7.97% |
Momentum Score | HIMS: A | Industry [X] | AZTA: A | INSP: A | TXG: D |
---|---|---|---|---|---|
Zacks Rank | 3 | 3 | 3 | 3 | |
VGM Score | A | A | B | F | |
Daily Price Chg | -4.98% | -0.91% | -8.93% | 28.14% | -3.92% |
1 Week Price Chg | -24.48% | -4.85% | -14.70% | 33.56% | -12.29% |
4 Week Price Chg | -20.63% | 0.00% | 5.15% | 43.41% | 15.40% |
12 Week Price Chg | 15.90% | -19.47% | 2.97% | 17.92% | -31.30% |
52 Week Price Chg | 119.13% | -49.09% | -8.02% | -21.67% | -65.37% |
20 Day Average Volume | 10,692,379 | 227,029 | 479,615 | 695,647 | 2,205,716 |
(F1) EPS Est. Wkly Chg | 15.15% | 0.00% | 11.18% | 373.68% | 0.00% |
(F1) EPS Est. Mthly Chg | 14.32% | 0.00% | 5.00% | 340.56% | -0.58% |
(F1) EPS Est. Qtrly Chg | 27.07% | 0.51% | 11.18% | 340.56% | 1.23% |
(Q1) EPS Est. Mthly Chg | 24.31% | 0.00% | -15.63% | 0.00% | 0.17% |
Zacks News for HIMS
Hims & Hers Health, Inc. (HIMS) Q2 Earnings and Revenues Beat Estimates
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services